Cancer vaccines could be available to patients by 2030, the German couple behind the Pfizer-BioNTech vaccine, one of the most effective jabs against Covid-19, have claimed. Professors Ugur Sahin and Ozlem Tureci told BBC's 'Sunday with Laura Kuenssberg' that they "feel that a cure for cancer or to changing cancer patients' lives is in our grasp." The couple co-founded the biotech company BioNTech in Mainz in 2008. Commenting on the possible timeline, Sahin said that cancer vaccines could become globally available "before 2030." However, they also attempted to strike a more cautious tone. "As scientists we are always hesitant to say we will have a cure for cancer," Tureci said, although she hinted that their company has had "a number of breakthroughs." According to the scientists, one of the possible consequences of the pandemic was that it could have hastened the invention of a cancer vaccine. Tureci noted that while BioNTech's achievements in the sphere of cancer vaccine development